1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Europe

Chronic Disease Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Euromonitor International
1-24 of 24 reports

Cough, Cold and Allergy (Hay Fever) Remedies in Estonia

  • $ 990
  • October 2021
  • 23 pages

Sales of cough, cold and allergy (hay fever) remedies continue to be impacted by COVID-19 in 2021, registering further double-digit current value decline. Consumers continue to take precautions due to ...

  • Estonia
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Bosnia and Herzegovina

  • $ 990
  • October 2021
  • 23 pages

While cough, cold and allergy (hay fever) remedies saw significant growth during the review period on the back of the self-medication trend, it was hit hard by measures introduced to limit the spread of ...

  • Bosnia and Herzegovina
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Romania

  • $ 990
  • October 2021
  • 23 pages

The category suffered a strong decline in 2020 as Romanians were less exposed to germs due to social distancing and spending less time outside. The COVID-19 situation is easing in 2021, with very few restrictions ...

  • Romania
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom

  • $ 990
  • October 2021
  • 27 pages

Following government measures to stop the spread of COVID-19, the lockdown was extended until mid-Q2 2021. This meant that with fewer opportunities to go out, the general public mostly stayed indoors with ...

  • United Kingdom
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Greenhouse Gas Emissions

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • $ 990
  • September 2021
  • 27 pages

Following strong growth in 2020 due to COVID-19 and purchases of cough remedies and nasal sprays for use during self-quarantine, cough, cold and allergy (hay fever) remedies is projected to see a small ...

  • Norway
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Russia

  • $ 990
  • September 2021
  • 26 pages

The epidemiologic situation regarding seasonal cold and flu has improved in Russia in 2021. Due to social distancing, the wearing of face masks and improved hygiene practices, there has not been the usual ...

  • Russia
  • Hay
  • Allergy
  • Industry analysis
  • Disposable Income
  • Birth Rate

Cough, Cold and Allergy (Hay Fever) Remedies in Greece

  • $ 990
  • September 2021
  • 25 pages

Cough, cold and allergy (hay fever) remedies looks set to record a steep decline in total current value sales in 2021, with most product categories also projected to post negative results in volume terms. Cough, ...

  • Greece
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Croatia

  • $ 990
  • September 2021
  • 22 pages

As was the case for other consumer health products in Croatia, cough, cold and allergy (hay fever) remedies saw heightened sales on the eve of lockdown in 2020 as nervous consumers stocked up on medications ...

  • Croatia
  • Allergy
  • Hay
  • Industry analysis
  • Re-Imbursed Pharmaceutical
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine

  • $ 990
  • September 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies are expected to register a value decline in 2021, with social distancing measures imposed to curb the spread of COVID-19, also curbing the spread of the common ...

  • Ukraine
  • OTC
  • Hay
  • Industry analysis
  • Prescription Drug Sales
  • Vitamin Sales

Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

  • $ 990
  • September 2021
  • 25 pages

Cough, cold and allergy (hay fever) remedies are expected to see a second year of decline in 2021, with social distancing measures imposed to curb the spread of COVID-19, also curbing the spread of the ...

  • Netherlands
  • Allergy
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Smoking Prevalence

Cough, Cold and Allergy (Hay Fever) Remedies in Italy

  • $ 990
  • September 2021
  • 26 pages

Sales of cough, cold and allergy (hay fever) remedies are expected to continue to decline significantly in 2021, with a double-digit fall in both current and constant value terms. The demand for cough, ...

  • Italy
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden

  • $ 990
  • September 2021
  • 24 pages

After seeing a notable decline in current value terms in 2020, cough, cold and allergy (hay fever) remedies is set to continue this negative trend in 2021. Cough, Cold and Allergy (Hay Fever) Remedies ...

  • Sweden
  • Allergy
  • Hay
  • Industry analysis
  • Life Expectancy
  • Store Closures

Cough, Cold and Allergy (Hay Fever) Remedies in Slovakia

  • $ 990
  • September 2021
  • 24 pages

The spread of COVID-19 led to consumers using more analgesics or Rx products after talking with their doctors and receiving their recommendations on how to treat the virus. Cold illnesses have been less ...

  • Slovakia
  • Hay
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Denmark

  • $ 990
  • September 2021
  • 24 pages

Cough, cold and allergy remedies is expected to register a small increase in current value sales in 2021 as the segment corrects itself after the decline in 2020, which was caused by a smaller prevalence ...

  • Denmark
  • OTC
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Finland

  • $ 990
  • September 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies is expected to register negative current value growth for the second year running, though the decline will not be as significant as in 2020, when it was in ...

  • Finland
  • OTC
  • Allergy
  • Industry analysis
  • Over The Counter Drug Sales
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in France

  • $ 990
  • September 2021
  • 26 pages

Retail current value sales of cough, cold and allergy (hay fever) remedies will decline for the fifth year in a row during 2021, albeit at a much more modest pace than in the previous year. With measures ...

  • France
  • OTC
  • Allergy
  • Industry analysis
  • Prescription Drug Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Poland

  • $ 990
  • September 2021
  • 28 pages

Cough, cold and allergy (hay fever) remedies is set to experience further declines in 2021 following a significant drop in demand the previous year after the emergence of the pandemic in Poland. Cough, ...

  • Poland
  • Allergy
  • Hay
  • Industry analysis
  • Prescription Drug Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Spain

  • $ 990
  • September 2021
  • 25 pages

One of the key factors that has supported sales growth in cough, cold and allergy (hay fever) remedies since the onset of the COVID-19 pandemic is the high numbers of people looking for cough remedies, ...

  • Spain
  • Allergy
  • Hay
  • Industry analysis
  • Online Retail Sales
  • Disposable Income

Cough, Cold and Allergy (Hay Fever) Remedies in Bulgaria

  • $ 990
  • September 2021
  • 24 pages

2020 was a challenging year for cough cold and allergy remedies brand owners as the COVID-19 pandemic replaced traditional colds and flus, significantly reducing demand for the category in the year. Paediatric ...

  • Bulgaria
  • Allergy
  • Hay
  • Industry analysis
  • Life Expectancy
  • Number Of Enterprises

Cough, Cold and Allergy (Hay Fever) Remedies in Belgium

  • $ 990
  • September 2021
  • 29 pages

Cough, cold and allergy (hay fever) remedies is showing notably lower declines in 2021 compared to the steep drops seen in 2020. This is only in part due to the mild winter season between December 2019 ...

  • Belgium
  • OTC
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in the Czech Republic

  • $ 990
  • September 2021
  • 25 pages

The incidence of the flu virus was insignificant in the winter of 2021 compared to previous years. It is estimated that there were about 1,050 patients with acute respiratory infections per 100,000 inhabitants. ...

  • Czech Republic
  • OTC
  • Allergy
  • Industry analysis
  • Health Insurance Claims
  • Online Retail Sales

Austria in 2040: The Future Demographic

  • $ 990
  • August 2021
  • 17 pages

Strong net migration will be the key driver of rapid population expansion in Austria in 2020-2040. Ageing will continue to accelerate, impacting consumer trends. Rapid growth in the number of foreign citizens, ...

  • Austria
  • Urban Development
  • Healthcare
  • Country analysis
  • Life Expectancy
  • Fertility Rate

Finland in 2040: The Future Demographic

  • $ 990
  • August 2021
  • 17 pages

After reaching a peak in 2031, Finland’s population is set to decline up to 2040 as rates of natural decrease rise. Ageing will be a key trend over this timeframe, resulting in a transformation of consume ...

  • Finland
  • Healthcare
  • Diabetes
  • Country analysis
  • Net Migration Rate
  • Life Expectancy

Lithuania in 2040: The Future Demographic

  • $ 990
  • June 2021
  • 17 pages

In 2020-2040 natural decrease will drive sustained depopulation in Lithuania, while negative net migration rates will contribute to a lesser extent. The ageing trend will gain pace with Lithuania continuing ...

  • Lithuania
  • Diabetes
  • Healthcare
  • Country analysis
  • Net Migration Rate
  • Life Expectancy


About 200 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Respiratory Disease Demographic Impact in Wales (UK)

  • October 2021
  • 9 pages
  • Wales
  • Influenza
  • Respiratory Disease
  • Industry analysis
  • Vaccination Coverage
  • Influenza Prevalence

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on